ALLMedicine™ Psoriasis Center

Sep 23rd, 2021 - Psoriasis is an autoimmune, chronic proliferative, inflammatory skin disease with high comorbidity. Psoriasis is not a curable disease; it can only be managed. Cyclosporine A (CyA) is one of the FDA-approved immunosuppressant drug used in severe P...

Sep 23rd, 2021 - Many patients with chronic itch and atopic dermatitis (AD) or psoriasis do not receive/use available medical and psychosocial treatments properly due to system, provider, and/or patient factors. An educational website (ITCH-RELIEF) to improve itch...

Sep 23rd, 2021 - Psoriasis, psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are chronic inflammatory diseases that often affect women of childbearing age. Detailed information about pregnancy and related outcomes across these indications in patients ...

Sep 23rd, 2021 - Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing COVID-19 pandemic has affected both daily life and medical care; therefore, the aim of this study was to analyze the use of ...

Sep 22nd, 2021 - Psoriasis is a chronic, immune-mediated inflammatory disease which pathogenesis is closely linked to γδ T cells. Recently, a critical role for butyrophilin 3A1 (BTN3A1) in mediating the activation of Vγ9Vδ2 T cells, which are reported to redistrib...

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

Dec 11th, 2020 - Psoriasis is a highly prevalent chronic, inflammatory multisystem disease with a considerable impact on patients' quality of life and the healthcare system. This report presents the recommendations developed by the Portuguese Psoriasis Group of th...

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Sep 7th, 2020 - To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and...

Jul 21st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. With 49% of the U.S. population fully vaccinated against SARS-CoV-2, a new study highlights the degree of vaccine hesitancy among patients with rh...

Jul 14th, 2021 - Psoriasis is a systemic inflammatory disease that is frequently accompanied by comorbidities, including metabolic syndrome, cardiovascular diseases, and depression. Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that develops in pat...

Jul 12th, 2021 - People taking methotrexate had low antibody responses after the first dose of the Pfizer–BioNTech mRNA COVID-19 vaccine, but did show evidence of T-cell-mediated immune responses, findings from a small study show. The common immunosuppressant has ...

Jul 9th, 2021 - Psoriasis is a chronic, immune-mediated inflammatory skin disease. Globally, approximately 125 million people have psoriasis, which manifests in several ways (ie, plaque, flexural, guttate, pustular, or erythrodermic psoriasis). Plaque psoriasis i...

Jul 9th, 2021 - Plaque psoriasis is the most common form of psoriasis, a chronic inflammatory skin disorder that affects approximately 125 million individuals worldwide. It exerts a considerable burden on affected patients, including decreased quality of life and...